255 related articles for article (PubMed ID: 20847637)
1. Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.
Llano DA; Laforet G; Devanarayan V;
Alzheimer Dis Assoc Disord; 2011; 25(1):73-84. PubMed ID: 20847637
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
3. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
4. The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.
Skinner J; Carvalho JO; Potter GG; Thames A; Zelinski E; Crane PK; Gibbons LE;
Brain Imaging Behav; 2012 Dec; 6(4):489-501. PubMed ID: 22614326
[TBL] [Abstract][Full Text] [Related]
5. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
6. Examining the reliability of ADAS-Cog change scores.
Grochowalski JH; Liu Y; Siedlecki KL
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for predicting cognitive decline in those with normal cognition.
Steenland K; Zhao L; Goldstein F; Cellar J; Lah J
J Alzheimers Dis; 2014; 40(3):587-94. PubMed ID: 24496071
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.
Herholz K; Westwood S; Haense C; Dunn G
J Nucl Med; 2011 Aug; 52(8):1218-26. PubMed ID: 21764801
[TBL] [Abstract][Full Text] [Related]
9. The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials.
Raghavan N; Samtani MN; Farnum M; Yang E; Novak G; Grundman M; Narayan V; DiBernardo A;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S21-31. PubMed ID: 23127469
[TBL] [Abstract][Full Text] [Related]
10. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
Wang X; Li F; Tian J; Gao Q; Zhu H
Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
[TBL] [Abstract][Full Text] [Related]
11. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
[TBL] [Abstract][Full Text] [Related]
12. Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.
Sano M; Raman R; Emond J; Thomas RG; Petersen R; Schneider LS; Aisen PS
Alzheimer Dis Assoc Disord; 2011; 25(2):122-7. PubMed ID: 20921876
[TBL] [Abstract][Full Text] [Related]
13. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
Pyo G; Elble RJ; Ala T; Markwell SJ
Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
[TBL] [Abstract][Full Text] [Related]
15. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.
Lorenzi M; Donohue M; Paternicò D; Scarpazza C; Ostrowitzki S; Blin O; Irving E; Frisoni GB;
Neurobiol Aging; 2010 Aug; 31(8):1443-51, 1451.e1. PubMed ID: 20541287
[TBL] [Abstract][Full Text] [Related]
16. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
[TBL] [Abstract][Full Text] [Related]
17. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
Papp E; Pákáski M; Drótos G; Kálmán J
Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
[TBL] [Abstract][Full Text] [Related]
18. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
[TBL] [Abstract][Full Text] [Related]
19. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
